The health ministry on Saturday recommended the use of antiviral drug remdesivir in moderate stage of COVID-19 while backtracking from its earlier stance on hydroxychloroquine, saying the......
Scaling up testing capacity, over seven lakh samples have been examined for COVID-19 in a day taking the cumulative tests conducted so far to 2,41,06,535, the Union health ministry said on Sunday.......
Global Covid case surge due to the Omicron variant led to a peak six times the previous waves but India managed to control its spread causing lower hospitalisation and fewer deaths than earlier......
The number of people who have recuperated from COVID-19 in India went past 19 lakh on Monday with a record 57,584 patients recovering within a span of 24 hours, pushing the recovery rate to over 72......
Omicron variant is the dominant variant in the country presently and the current surge of COVID-19 cases in the country is showing a sustained declining trend since January 21, Union Health......
In India, itolizumab, known by the brand name Alzumab, has been priced at Rs 8,000 per vial. Most patients require four vials for Covid-19 treatment, taking the cost of the therapy to Rs 32,000.......